The California Stem Cell Report: Authoritative, Respected, Independent, Unique and 'Essential'
Subscribe today to stay on top of what's next for the Golden State’s research billions.
So what’s the value proposition in a subscription to the California Stem Cell Report, to borrow a favorite term of a former president of the California stem cell agency?
No. 1 -- The California Stem Cell Report is the only independent, regular source of news and information about the California Institute for Regenerative Medicine (CIRM). The articles that the Report carries can be found nowhere else.
No. 2 -- The California Stem Cell Report is authoritative and has a deep history with CIRM. Yours truly has followed the agency since 2004, longer than any member of the CIRM staff has been employed there. The Report has been widely quoted when mainstream media outlets carry stories about the $12 billion effort.
No. 3 -- The California Stem Cell Report is respected. It has been described as "essential" reading by the Los Angeles Times. Zach Hall, the first president of the stem cell agency, said the Report has the "best commentary and analysis by far on the California stem cell project.” I was an invited witness before the National Academy of Medicine panel that spent 12 months studying CIRM. I was also invited to testify before the California Legislature’s Select Committee on Biotechnology. In 2020, I published the only book — “California’s Great Stem Cell Experiment” — that chronicles the life and times of CIRM, for better or worse.
No. 4 -- The story of the California stem cell agency is far from complete. The agency is on an incredible and tricky ride. And it involves -- in a unique way -- Big Science, Big Academia, Big Business, Big Politics, Big Government, morality, ethics and hope, not to mention life and death. And its affairs are seriously underreported in the mainstream media. What CIRM does could well affect your professional or personal life or those of your family.
No. 5 — 2024 will be the most consequential year in CIRM’s life since 2020, when it narrowly avoided financial extinction. Coming up next year will be the selection of a new president, a re-examination of CIRM priorities, perhaps real progress on its affordability mandate and new plans for handing out $1.5 billion for neuroscience research.
No. 6 -- As a paid subscriber, you will be among readers who include researchers around the nation and a few globally as well as policymakers in Sacramento and Washington, folks in the biomedical industry, patients, journalists and others simply interested in this novel enterprise.
Did I forget to mention that CIRM is the world’s largest institution dedicated to regenerative medicine? It is also the largest state stem cell research effort in the nation.
Please subscribe either free or paid. You will continue to receive choice morsels with a free subscription — but not as often as with paid — plus the headlines from other articles. A paid subscription will provide you with more — at a modest price, $8.00 a month, less than what you would pay for a San Francisco latte. Plus, the most timely information is part of the paid package. (News is like fish; it is best served fresh.)
Not only will a paid subscription keep you on top of important CIRM affairs, it will give you access to more than 5,000 items about the agency dating back 19 years via a nifty search engine provided by Substack. As always, you can address me at djensen@californiastemcellreport.com. Thank you.